H.C. Wainwright Downgrades Principia Biopharma (PRNB) to Neutral
Tweet
Share
E-mailGet Alerts PRNB Hot Sheet
Price: $100.05 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis downgraded Principia Biopharma (NASDAQ: PRNB) from Buy to Neutral with a price target of $100.00 (from $108.00).
For an analyst ratings summary and ratings history on Principia Biopharma click here. For more ratings news on Principia Biopharma click here.
Shares of Principia Biopharma closed at $99.25 yesterday.
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
